Literature DB >> 3223280

Carcinoid tumor of the middle ear. An immunohistochemical and electron microscopic study. Report of a case.

M Sakurai1, N Mori, O Horiuchi, N Matsuura, Y Kobayashi.   

Abstract

A primary tumor of the middle ear was examined histologically, histochemically, immunohistochemically and ultrastructurally. Neuroendocrine cell differentiation, a carcinoid feature, was demonstrated by the presence of numerous argyrophil granules, as well as positive serotonin, glicentin, glucagon, and human pancreatic polypeptide (hPP) granules in some of the Grimelium-positive cells. Chromogranin A was also detected in the cells, but much less frequently than Grimelius-positive staining. Neither neuron-specific enolase (NSE) nor epithelial membrane antigen (EMA) was demonstrated in the tumor. Mucin was demonstrated only intraluminally. Electron microscopy revealed many typical neurosecretory granules in tumor cells, but no apical mucin granules. The tumor appeared to be benign, and there has been no sign of recurrence during a postoperative period of one year.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3223280     DOI: 10.1111/j.1440-1827.1988.tb01087.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  4 in total

1.  Carcinoid tumor of the middle ear in a 28-year-old patient.

Authors:  H Bläker; G Dyckhoff; H Weidauer; H F Otto
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  Well-differentiated endocrine tumours of the middle ear and of the hindgut have immunocytochemical and ultrastructural features in common.

Authors:  C Azzoni; M Bonato; T D'Adda; L Usellini; F Piazza; A Gandolfi; C Bordi; C Capella
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series.

Authors:  Issam Saliba; Anne-Sophie Evrard
Journal:  Cases J       Date:  2009-03-13

Review 4.  Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.

Authors:  Ronald S Duman; Ryota Shinohara; Manoela V Fogaça; Brendan Hare
Journal:  Mol Psychiatry       Date:  2019-03-20       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.